Anna Morris KC addresses Module 4 Preliminary Hearing in Covid-19 Inquiry

14 September 2023

Anna Morris KC and Christian Weaver, instructed by Terry Wilcox at Hudgells Solicitors, represent over 1,000 people who have suffered an adverse reaction or bereavement as a result of the Covid-19 vaccine.

Yesterday, in their opening statement to the UK Covid-19 Inquiry preliminary hearing for Module 4, which will focus on vaccines and therapeutics, they highlighted the historic opportunity the Inquiry has to listen, acknowledge and record the experiences of the vaccine injured, and to radically reform the medical, psychological and financial support they receive.

Anna Morris KC leads the team which represents the Vaccine Injured and Bereaved UK, Scottish Vaccine Injury Group, and UK CV Family, alongside GCN’s Christian Weaver and Mark Bradley from Deans Court Chambers.

You can read a transcript of the hearing.

Media coverage of Anna’s appearance can be found below:
Daily Mail Online
The Herald

Chambers news

Chambers news

The Legal 500 Bar Awards 2025: Garden Court North Chambers nominated for Set Outside London of the Year

Garden Court North Chambers has been shortlisted as Set Outside London of the Year for The Legal 500 Bar Awards 2025.

Chambers news

167 cross-party MPs and Lords sign letter calling for an undiluted Hillsborough Law

138 MPs and 29 Lords have signed a letter calling for the UK Government to deliver a full and undiluted ‘Hillsborough Law’.

Chambers news

Covid-19 Inquiry: Module 6 public hearings begin on adult social care sector

On 30 June 2025, public hearings will begin for Module 6 of the Covid-19 Inquiry, investigating the pandemic’s impact on adult social care.

Chambers news

Garden Court North’s protest rights team to host ‘Understanding Anti-Zionism’ webinar with Professor Avi Shlaim

On 7 July, Garden Court North's protest rights team will host an exclusive webinar on 'Understanding Anti-Zionism' alongside Professor Avi Shlaim.

Sign up to our mailing list

Our mailing list is dedicated to professionals with an interest in our work.

Sign up